Literature DB >> 34182130

The role of extracellular vesicles in regulating local and systemic inflammation in cardiovascular disease.

Lee Ohayon1, Xinyi Zhang2, Partha Dutta3.   

Abstract

Extracellular vesicles are heterogeneous structures surrounded by cell membranes and carry complex contents including nucleotides, proteins, and lipids. These proteins include cytokines and chemokines that are important for exaggerating local and systemic inflammation in disease. Extracellular vesicles are mainly categorized as exosomes and micro-vesicles, which are directly shed from the endosomal system or originated from the cell membrane, respectively. By transporting several bioactive molecules to recipient cells and tissues, extracellular vesicles have favorable, neutral, or detrimental impacts on their targets, such as switching cell phenotype, modulating gene expression, and controlling biological pathways such as inflammatory cell recruitment, activation of myeloid cells and cell proliferation. Extracellular vesicles mediate these functions via both autocrine and paracrine signaling. In the cardiovascular system, extracellular vesicles can be secreted by multiple cell types like cardiomyocytes, smooth muscle cells, macrophages, monocytes, fibroblasts, and endothelial cells, and affect functions of cells or tissues in distant organs. These effects involve maintaining homeostasis, regulating inflammation, and triggering pathological process in cardiovascular disease. In this review, we mainly focus on the role of micro-vesicles and exosomes, two important subtypes of extracellular vesicles, in local and systemic inflammation in cardiovascular diseases such as myocardial infarction, atherosclerosis and heart failure. We summarize recent findings and knowledge on the effect of extracellular vesicles in controlling both humoral and cellular immunity, and the therapeutic approaches to harness this knowledge to control exacerbated inflammation in cardiovascular diseases.
Copyright © 2021 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Exosomes; Extracellular vesicles; Inflammation; MicroRNA

Mesh:

Substances:

Year:  2021        PMID: 34182130      PMCID: PMC8338901          DOI: 10.1016/j.phrs.2021.105692

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   10.334


  180 in total

1.  Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination.

Authors:  Guillaume van Niel; Richard Wubbolts; Toine Ten Broeke; Sonja I Buschow; Ferry A Ossendorp; Cornelis J Melief; Graca Raposo; Bas W van Balkom; Willem Stoorvogel
Journal:  Immunity       Date:  2006-12       Impact factor: 31.745

2.  Identification of a circulating microvesicle protein network involved in ST-elevation myocardial infarction.

Authors:  Paula Vélez; Andrés F Parguiña; Raymundo Ocaranza-Sánchez; Lilian Grigorian-Shamagian; Isaac Rosa; Sergio Alonso-Orgaz; Fernando de la Cuesta; Esteban Guitián; José Moreu; María G Barderas; José Ramón González-Juanatey; Ángel García
Journal:  Thromb Haemost       Date:  2014-07-10       Impact factor: 5.249

Review 3.  Extracellular Vesicles: Unique Intercellular Delivery Vehicles.

Authors:  Sybren L N Maas; Xandra O Breakefield; Alissa M Weaver
Journal:  Trends Cell Biol       Date:  2016-12-13       Impact factor: 20.808

4.  E-Selectin Inhibition Mitigates Splenic HSC Activation and Myelopoiesis in Hypercholesterolemic Mice With Myocardial Infarction.

Authors:  Partha Dutta; Friedrich Felix Hoyer; Yuan Sun; Yoshiko Iwamoto; Benoit Tricot; Ralph Weissleder; John L Magnani; Filip K Swirski; Matthias Nahrendorf
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-28       Impact factor: 8.311

5.  MicroRNA-126-5p promotes endothelial proliferation and limits atherosclerosis by suppressing Dlk1.

Authors:  Andreas Schober; Maliheh Nazari-Jahantigh; Yuanyuan Wei; Kiril Bidzhekov; Felix Gremse; Jochen Grommes; Remco T A Megens; Kathrin Heyll; Heidi Noels; Michael Hristov; Shusheng Wang; Fabian Kiessling; Eric N Olson; Christian Weber
Journal:  Nat Med       Date:  2014-03-02       Impact factor: 53.440

6.  High glucose condition increases NADPH oxidase activity in endothelial microparticles that promote vascular inflammation.

Authors:  Felix Jansen; Xiaoyan Yang; Bernardo S Franklin; Marion Hoelscher; Theresa Schmitz; Jörg Bedorf; Georg Nickenig; Nikos Werner
Journal:  Cardiovasc Res       Date:  2013-01-22       Impact factor: 10.787

Review 7.  The Exosome: a New Player in Diabetic Cardiomyopathy.

Authors:  Lichan Tao; Jia Shi; Xiaoyu Yang; Ling Yang; Fei Hua
Journal:  J Cardiovasc Transl Res       Date:  2018-09-24       Impact factor: 4.132

8.  Circulating exosomal miR-92b-5p is a promising diagnostic biomarker of heart failure with reduced ejection fraction patients hospitalized for acute heart failure.

Authors:  Tao Wu; Yichen Chen; Yantao Du; Jin Tao; Wei Li; Zhong Zhou; Zhuo Yang
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

9.  High-resolution proteomic and lipidomic analysis of exosomes and microvesicles from different cell sources.

Authors:  Reka A Haraszti; Marie-Cecile Didiot; Ellen Sapp; John Leszyk; Scott A Shaffer; Hannah E Rockwell; Fei Gao; Niven R Narain; Marian DiFiglia; Michael A Kiebish; Neil Aronin; Anastasia Khvorova
Journal:  J Extracell Vesicles       Date:  2016-11-17

10.  Low MT-CO1 in Monocytes and Microvesicles Is Associated With Outcome in Patients With Coronary Artery Disease.

Authors:  Paul Holvoet; Maarten Vanhaverbeke; Katarzyna Bloch; Pieter Baatsen; Peter Sinnaeve; Stefan Janssens
Journal:  J Am Heart Assoc       Date:  2016-12-05       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.